Opportunities in Indian Pharma Sector", report provides extensive
research and objective analysis on the Pharmaceutical sector in India. This
report has been written to helps clients in analyzing the opportunities critical
to the growth of Pharmaceutical market in India. Detailed data and analysis will
help the investors to comprehend the changing dynamics of the Pharmaceutical
industry.
Key Findings
§ India currently holds U.S. $6 billion of the $550 billion global
pharmaceutical industry but its share is increasing at 10 % a year. When
compared to 7 % annual growth for the world markets overall, this speaks of a
very promising scenario.
§ Domestic pharmaceutical companies will increasingly be looking to consolidate
across the value chain by forming partnerships or merging with companies that
have complementary strengths. As drug discovery becomes more expensive, and the
costs of administration and regulatory compliance continue to rise, these
partnerships will become more central to pharma companies' business proposition.
§ The Bio Pharmaceutical market is seeing a consistent growing trend with 2004
seeing a record vaccine sales of US$386.3 Million and Marketing licenses granted
for over 25 recombinant therapeutic protein. The Diagnostics market also sees a
Sales market for US$138.2 Million.
Key Issues and Facts Analyzed
The research report also addresses the issues and facts that are critical to
your success:
§ What are the emerging trends in the Pharmaceutical sector in India?
§ What are the key regulations and the policy environment in the industry?
§ What is the future scenario of the Pharmaceutical market in India?
§ Who are the Key players in the Pharmaceutical Market in India?
§ What opportunities exist for the Pharmaceutical market?
§ What Challenges are faced by the industry?
§ How the market is affected by other factors prevailing in the economy?
Key Players Analyzed
This section provides the overview, key facts and financial information and key
competitors of prominent players in the Indian Pharmaceutical market like Cipla,
Ranbaxy Ltd, Dr Reddy ‘s Lab, Nicolas Piramal, Biocon, Dabur Ltd, Sun
Pharmaceuticals, Wockhardt, GlaxoSmithkline and Aventis etc.
Research Methodology
Information Sources
Books, Newspapers, Trade Journals, and White papers, Industry portals,
Government Agencies, Trade associations. Monitoring Industry News and
developments, Access to more than 3000 paid databases.
Analysis Method
Ratio Analysis, Historical Trend Analysis, Linear Regression Analysis using
software tools, Judgmental Forecasting and Cause and Effect Analysis
